These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6982888)

  • 1. A simple method for testing the efficacy of a beta-lactamase inhibitor against beta-lactamase-producing gram-negative bacteria.
    Sawai T; Yoshida T
    J Antibiot (Tokyo); 1982 Aug; 35(8):1072-7. PubMed ID: 6982888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of beta-lactamase inhibition: differences between sulbactam and other inhibitors.
    Sawai T; Yamaguchi A
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):121S-129S. PubMed ID: 2591172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of aztreonam as a substrate, inhibitor and inducer for beta-lactamases.
    Sakurai Y; Yoshida Y; Saitoh K; Nemoto M; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1990 Apr; 43(4):403-10. PubMed ID: 2112533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of cloxacillin into a progressive inhibitor of beta-lactamases by sulfonation and its activity against various types of these enzymes.
    Yamaguchi A; Adachi A; Hirata T; Adachi H; Sawai T
    J Antibiot (Tokyo); 1985 Jan; 38(1):83-93. PubMed ID: 3871761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of beta-lactamase inhibitors].
    Hyodo A; Higashitani F; Nishida K; Kunugita C; Unemi N
    Nihon Rinsho; 1997 May; 55(5):1272-80. PubMed ID: 9155186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.
    Higashitani F; Hyodo A; Ishida N; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1990 Apr; 25(4):567-74. PubMed ID: 2161820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of beta-lactamase-producing strains isolated from urinary tract and their drug susceptibility].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1990 May; 36(5):569-75. PubMed ID: 2399858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of some cephalosporins and ampicillin on some beta-lactamase- and non-beta-lactamase-producing strains of gram-negative bacteria.
    Russell AD
    Microbios; 1974 Apr; 10(37):29-38. PubMed ID: 4604409
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
    Rotschafer JC; Ostergaard BE
    Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activity of ampicillin and cloxacillin. Protective effect of cloxacillin on enzymatic degradation of ampicillin by penicillinase, and therapeutic activity of mixtures of ampicillin and cloxacillin.
    Nishida M; Mine Y; Kuwahara S
    J Antibiot (Tokyo); 1969 Apr; 22(4):144-50. PubMed ID: 4895357
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholic acid: a novel steroidal uncompetitive inhibitor against β-lactamase produced by multidrug-resistant isolates.
    Rashid SA; Norman N; Teo SH; Tong WY; Leong CR; Tan WN; Noor MAM
    World J Microbiol Biotechnol; 2021 Aug; 37(9):152. PubMed ID: 34398332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
    Okonogi K; Harada S; Shinagawa S; Imada A; Kuno M
    J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling the Antibiotic Resistance Caused by Class A
    Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Lactamase inhibitor peptides as the new strategies to overcome bacterial resistance.
    Silva ON; Franco OL; Porto WF
    Drugs Today (Barc); 2018 Dec; 54(12):737-746. PubMed ID: 30596392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor.
    Niwa T; Yoshida T; Tamura A; Kazuno Y; Inouye S; Ito T; Kojima M
    J Antibiot (Tokyo); 1986 Jul; 39(7):943-55. PubMed ID: 3019978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synergistic activity of cloxacillin (Syntarpen 201) with other beta-lactam antibiotics against Gram-negative enteric bacteria].
    Bobrowski M; Gebicka K
    Pol Tyg Lek; 1971 May; 26(20):764-6. PubMed ID: 5580934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.